Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
Phone415-657-5500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$162.72 million
Profitability
Miscellaneous
Employees402
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable
Cutera (NASDAQ:CUTR) Frequently Asked Questions
What is Cutera's stock symbol?
Cutera trades on the NASDAQ under the ticker symbol "CUTR."
How will Cutera's stock buyback program work?
Cutera announced that its board has authorized a stock buyback program on Tuesday, August 8th 2017, which permits the company to buyback $25,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.
How were Cutera's earnings last quarter?
Cutera, Inc. (NASDAQ:CUTR) released its quarterly earnings data on Thursday, May, 9th. The medical device company reported ($0.59) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.30. The medical device company had revenue of $36 million for the quarter, compared to the consensus estimate of $33.45 million. Cutera had a negative return on equity of 65.62% and a negative net margin of 22.45%. The business's quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.02) earnings per share. View Cutera's Earnings History.
When is Cutera's next earnings date?
What price target have analysts set for CUTR?
4 equities research analysts have issued 1-year price objectives for Cutera's stock. Their forecasts range from $25.00 to $50.00. On average, they anticipate Cutera's stock price to reach $34.6667 in the next twelve months. This suggests a possible upside of 72.3% from the stock's current price. View Analyst Price Targets for Cutera.
What is the consensus analysts' recommendation for Cutera?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cutera.
What are Wall Street analysts saying about Cutera stock?
Here are some recent quotes from research analysts about Cutera stock:
- 1. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (5/15/2019)
- 2. Maxim Group analysts commented, "Market open, CUTR reported lower-than-expected preliminary 4Q18 revenue. The company also announced the resignation of CEO James Reinstein amid Board dissatisfaction with 2018 operational results and stock price performance. CUTR plans to report full 4Q18 results on Market close." (1/8/2019)
Has Cutera been receiving favorable news coverage?
Media headlines about CUTR stock have trended somewhat negative this week, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Cutera earned a media sentiment score of -1.2 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Cutera.
Are investors shorting Cutera?
Cutera saw a increase in short interest in May. As of May 15th, there was short interest totalling 562,300 shares, an increase of 8.6% from the April 15th total of 517,600 shares. Based on an average daily trading volume, of 169,600 shares, the short-interest ratio is presently 3.3 days. Currently, 4.1% of the shares of the company are sold short. View Cutera's Current Options Chain.
Who are some of Cutera's key competitors?
Some companies that are related to Cutera include Viewray (VRAY), Natus Medical (BABY), AxoGen (AXGN), TransMedics Group (TMDX), BioLife Solutions (BLFS), Zynex (ZYXI), Semler Scientific (SMLR), Rockwell Medical (RMTI), BioSig Technologies (BSGM), Stereotaxis (STXS), Fonar (FONR), Fc Global Realty (FCRE), Second Sight Medical Products (EYES), Soleno Therapeutics (SLNO) and Edap Tms (EDAP).
What other stocks do shareholders of Cutera own?
Who are Cutera's key executives?
Cutera's management team includes the folowing people:
- Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 53)
- Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 48)
- Mr. Ronald J. Santilli, Exec. Officer (Age 59)
- Mr. Jason Richey, Interim CEO & Chief Operating Officer
- Dr. Michael Karavitis, Exec. VP & Chief Technology Officer
Who are Cutera's major shareholders?
Cutera's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Gamco Investors INC. ET AL (7.85%), Paradigm Capital Management Inc. NY (5.95%), Gabelli Funds LLC (4.60%), Teton Advisors Inc. (2.80%), Kennedy Capital Management Inc. (1.50%) and Quantum Capital Management (1.28%). Company insiders that own Cutera stock include David A Gollnick, David B Apfelberg, Gregory A Barrett, J Daniel Plants, James A Reinstein, Larry Laber, Miguel Pardos, Ronald J Santilli and Timothy J Oshea. View Institutional Ownership Trends for Cutera.
Which major investors are selling Cutera stock?
CUTR stock was sold by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., NJ State Employees Deferred Compensation Plan and Teton Advisors Inc.. View Insider Buying and Selling for Cutera.
Which major investors are buying Cutera stock?
CUTR stock was bought by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Gamco Investors INC. ET AL, Eagle Asset Management Inc., Assenagon Asset Management S.A., Quantum Capital Management, Spark Investment Management LLC, Gabelli Funds LLC and 6 Meridian. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett, J Daniel Plants and James A Reinstein. View Insider Buying and Selling for Cutera.
How do I buy shares of Cutera?
Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cutera's stock price today?
One share of CUTR stock can currently be purchased for approximately $20.12.
How big of a company is Cutera?
Cutera has a market capitalization of $282.48 million and generates $162.72 million in revenue each year. The medical device company earns $-30,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. Cutera employs 402 workers across the globe.View Additional Information About Cutera.
What is Cutera's official website?
How can I contact Cutera?
Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]
MarketBeat Community Rating for Cutera (NASDAQ CUTR)
MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
